Drug Repurposing Track
Deadline for submission: September 20th 2025
|
This is the first joint Call for Proposals by SPARK TEL AVIV, TAU and Tel Aviv Sourasky Medical Center (ICHILOV) focusing on advancing Novel Therapeutics and Drug Repurposing to the clinic.
SPARK TEL AVIV is a mentoring program dedicated to accelerating scientific discoveries and expanding the societal impact of academic innovations. It is a member of the SPARK Global community, founded by Stanford University, and specializes in the field of translational medicine.
Our mission is to help researchers from TAU and TASMC navigate the challenges of translating their research discoveries into new therapies. The Drug Repurposing Track aims to support the transition from academic proof-of-concept research to robust preclinical and clinical studies that meet industry standards.
|
Drug Repurposing Track:
Drug Repurposing Track offers grants for the development of approved or investigational drugs that are outside the scope of the original medical indication.
Awarded projects will receive milestone-based funding for two years, up to $100,000 per project/year. Funded projects will also receive ongoing mentorship, access to expert advisors, and educational program throughout all stages of product development.
The program will support expenses needed for taking the project towards clinical study, including pre-clinical studies, patient profiling, regulatory consultancy, clinical trial protocol development, product design, and efforts required for clinical readiness.
For the call for proposal PDF version click here >>
|
Your Benefits:
- Funding to de-risk your project
- Advice from industry leaders and access to experts
- Project management support and mentorship
- Education on drug development and clinical readiness
- Membership in the global SPARK community and network
- Support for bringing your invention to the clinic
 |
 |
 |
Read More
